Replies to post #35171 on Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

Thank you JerryWinvest, looking forward to a trillion dollar company as J-Belfort puts it >>>>>>>>>>>>>

VIP participates in maintaining immune tolerance in two distinct ways: by regulating the balance between pro-inflammatory and anti-inflammatory factors, and by inducing the emergence of regulatory T cells with suppressive activity against autoreactive T cell effectors.

https://pubmed.ncbi.nlm.nih.gov/17934101/

The therapeutic effect of VIP was associated with downregulation of both inflammatory and autoimmune components of the disease. Our data indicate VIP as a viable candidate for the development of treatments for RA.

https://www.nature.com/articles/nm0501_563